EBA
UTMD icon

Eagle Bay Advisors’s Utah Medical Products UTMD Stock Holding History

Eagle Bay Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-21
Closed -$2K – 1282
2021
Q3 		$2K Hold
21
– – ﹤0.01% 998
2021
Q2 		$2K Buy
+21
New +$1.82K ﹤0.01% 850

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eagle Bay Advisors's UTMD Position: Q4 2021 in Review

Eagle Bay Advisors sold out of Utah Medical Products (UTMD) in Q4 2021, closing a stake of 21 shares — an estimated $2K sold.

Eagle Bay Advisors first reported a position in UTMD in Q2 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 79 funds tracked by Wall St. Rank hold UTMD as of Q4 2021.

  • Eagle Bay Advisors reported no remaining Utah Medical Products position as of Q4 2021 after selling out during the quarter.
  • Eagle Bay Advisors sold 21 Utah Medical Products shares in Q4 2021, an estimated $2K.
  • Eagle Bay Advisors first reported a position in Utah Medical Products in Q2 2021 and held it in 2 quarters.
  • Eagle Bay Advisors's Utah Medical Products position peaked at $2K in Q3 2021.
  • 79 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2021.

Based on Eagle Bay Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.